Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Reuben R. Zimmerman
WARNING LETTER
•Reuben R. Zimmerman•September 17, 2014

Reuben R. Zimmerman – FDA Warning Letter, Sep 17, 2014

Record Details

The FDA issued a Warning Letter to Rueben R. Zimmerman following an inspection of his dairy operation on September 15 and 17, 2014. The inspection revealed multiple violations of the Federal Food, Drug, and Cosmetic Act related to animal drug use and food adulteration. Specifically, the firm offered for sale a dairy cow for slaughter as food that was adulterated, containing penicillin and flunixin residues exceeding established tolerances (21 U.S.C. 342(a)(2)(C)(ii)). The firm was also found to hold animals under inadequate conditions, making it likely that medicated animals with harmful drug residues could enter the food supply, constituting adulterated food under 21 U.S.C. 342(a)(4), exemplified by a failure to maintain complete treatment records. Furthermore, the firm adulterated new animal drugs, Penicillin Injectable and Ceftiofur, through extralabel use not directed by approved labeling or veterinary prescription (21 U.S.C. 351(a)(5)). Specific extralabel use violations included administering penicillin without licensed veterinarian supervision (21 C.F.R. 530.11(a)) and resulting in illegal drug residue (21 C.F.R. 530.11(d)). Ceftiofur was also used extralabelly without licensed veterinarian supervision (21 C.F.R. 530.11(a)), with certain uses being prohibited by 21 C.F.R. 530.41(a)(13)(ii). The FDA requires prompt corrective action, including establishing procedures to prevent recurrence. A written response detailing corrective steps, timelines, and documentation is due within 15 working days. Failure to comply may lead to regulatory actions like seizure or injunction.

Company
Reuben R. Zimmerman
Inspection date
September 17, 2014
Product type
Drugs
Office
New York District Office
Person
  • Ronald M. Pace (Program Director)
View Company Profile

ID · a59e9ba0-0d97-4b94-bec6-2fa4c9cead74

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)21 CFR 530.11(d)21 CFR 530.41(a)(13)(ii)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Reuben R. Zimmerman
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.